BIOQUÍMICA Y BIOLOGÍA MOLECULAR II
DEPARTAMENTO
Hospital Clínico San Carlos de Madrid
Madrid, EspañaPublicaciones en colaboración con investigadores/as de Hospital Clínico San Carlos de Madrid (11)
2024
2022
-
High BMP4 expression in low/intermediate risk BCP-ALL identifies children with poor outcomes
Blood, Vol. 139, Núm. 22, pp. 3303-3313
2020
-
A cross-disease meta-GWAS identifies four new susceptibility loci shared between systemic sclerosis and Crohn’s disease
Scientific Reports, Vol. 10, Núm. 1
-
Is there evidence for bacterial transfer via the placenta and any role in the colonization of the infant gut?–a systematic review
Critical Reviews in Microbiology, Vol. 46, Núm. 5, pp. 493-507
2017
-
An MIF promoter polymorphism is associated with susceptibility to pulmonary arterial hypertension in diffuse cutaneous systemic sclerosis
Journal of Rheumatology, Vol. 44, Núm. 10, pp. 1453-1457
-
Resistance to Targeted Therapies in Renal Cancer: The Importance of Changing the Mechanism of Action
Targeted Oncology, Vol. 12, Núm. 1, pp. 19-35
2016
-
Brief Report: IRF4 Newly Identified as a Common Susceptibility Locus for Systemic Sclerosis and Rheumatoid Arthritis in a Cross-Disease Meta-Analysis of Genome-Wide Association Studies
Arthritis and Rheumatology, Vol. 68, Núm. 9, pp. 2338-2344
2015
-
Consenso sobre las grasas y aceites en la alimentación de la población española adulta; postura de la Federación Española de Sociedades de Alimentación, Nutrición y Dietética (FESNAD)
Nutricion Hospitalaria, Vol. 32, Núm. 2, pp. 435-477
2014
-
A genome-wide association study follow-up suggests a possible role for PPARG in systemic sclerosis susceptibility
Arthritis Research and Therapy, Vol. 16, Núm. 1
2013
-
Documento de consensoy conclusiones: Obesidad y sedentarismo en el siglo XXI: ¿qué se puede y se debe hacer?
Nutricion Hospitalaria, Vol. 28, Núm. SUPPL.5, pp. 1-12
2011
-
No evidence for association between the CCR5/Delta32CCR5 polymorphism and systemic sclerosis
Clinical and Experimental Rheumatology